PharmacologyChurchill Livingstone, 2001 - 839 pagine Adapted for the U.S., this New Edition of PHARMACOLOGY, a popular UK text, describes what drugs do and emphasizes the mechanisms by which they act. The U.S. edition is revised and updated to reflect the substantial differences in drug names, FDA approvals, terminology, and guidelines for use. It also boasts new and revised chapters to ensure that students are up to date on the very latest information. Each chapter begins with a summary of information essential to the chapter and key points are highlighted within the text to alert students to crucial concepts. Spanish version also available, ISBN: 84-8174-492-1 |
Dall'interno del libro
Risultati 1-3 di 78
Pagina 103
... mainly by affecting calcium entry into the nerve terminal ( see Stjarne 1989 , Wu & Saggau 1997 ) . When a nerve terminal is depolarized by an action potential , voltage- gated N - type calcium channels open ( see Fig . 6.10 , below ) ...
... mainly by affecting calcium entry into the nerve terminal ( see Stjarne 1989 , Wu & Saggau 1997 ) . When a nerve terminal is depolarized by an action potential , voltage- gated N - type calcium channels open ( see Fig . 6.10 , below ) ...
Pagina 113
... mainly on CNS and peripheral neurons and gastric parietal cells . They mediate excitatory effects , for example the slow muscarinic excitation mediated by acetylcholine in sympathetic ganglia ( Ch . 6 ) and central neurons . This ...
... mainly on CNS and peripheral neurons and gastric parietal cells . They mediate excitatory effects , for example the slow muscarinic excitation mediated by acetylcholine in sympathetic ganglia ( Ch . 6 ) and central neurons . This ...
Pagina 485
... mainly in the pons and medulla , one important such cell group being the locus ceruleus . • Noradrenergic pathways , running mainly in the medial forebrain bundle and descending spinal tracts , terminate diffusely in the cortex ...
... mainly in the pons and medulla , one important such cell group being the locus ceruleus . • Noradrenergic pathways , running mainly in the medial forebrain bundle and descending spinal tracts , terminate diffusely in the cortex ...
Sommario
general principles | 11 |
molecular aspects | 19 |
Method and measurement in pharmacology | 47 |
Copyright | |
45 sezioni non visualizzate
Altre edizioni - Visualizza tutto
Parole e frasi comuni
5-HT receptors absorption acetylcholine action potential activity adrenoceptors agents agonists amino acids anesthetics antidepressant antipsychotic asthma benzodiazepines binding block blood bradykinin brain Ca2+ cancer cardiac cause cells chemical cholinergic clinical compounds cytokines decrease depolarization depression disease diuretics dopamine dose drugs enzyme estrogens ethanol excretion factors function GABA gastrointestinal gene glucocorticoids glucose glutamate histamine hormone important inactivation increase inflammatory inhibition inhibitors injection insulin interaction intracellular intravenous kinase leptin liver mainly mechanism of action mediators membrane metabolism metabolites molecular molecules morphine muscarinic nerve terminals neurons nicotine norepinephrine normal occurs opioid orally oxide pathway patients peptide peripheral Pharmacokinetic Pharmacol pharmacological physiological pituitary plasma concentration platelet presynaptic produce prostaglandins protein reactions receptor antagonists reduced release renal response result role secretion side-effects smooth muscle sodium stimulation substance sympathetic synaptic synthesis therapeutic therapy tissue toxicity transmission transmitter treatment tubule unwanted effects uptake vascular vasoconstriction vitamin